INTRODUCTION

Top Abstract Introduction Materials and Methods Results Discussion References

Cryptococcosis is a life-threatening disease caused by the encapsulated fungus Cryptococcus neoformans. The disease is generally thought to be acquired via inhalation and, following dissemination of the organism into the bloodstream, the disease generally is manifested as often fatal meningoencephalitis (27, 33). The incidence of cryptococcosis has increased significantly as a result of the growing number of immunocompromised individuals, due to the expanding use of immunosuppressive drugs and to the spread of human immunodeficiency virus. Loss of CD4⁺ T cells predisposes individuals to progressive infection with C. neoformans, emphasizing the importance of cell-mediated immunity (CMI) in host resistance to this organism, and may explain the high incidence of cryptococcosis in AIDS patients with reduced CD4⁺ T-cell numbers. Immunocompromised individuals suffering from cryptococcosis must remain on antifungal therapy for life because the currently available drugs do not completely eradicate the organism from the body (45).

Many reports have described pulmonary infection with C. neoformans and the immune events and interactions taking place in the lungs following infection (19, 20, 22, 32, 35). It is clear that CD4⁺ T lymphocytes and the development of CMI are required for the clearance of the organism from pulmonary and other non-central nervous system (CNS) sites of infection in animal models (6, 14-17, 20, 22, 23, 31, 35, 41, 46). Certain cytokines, such as gamma interferon (IFN-), have also been implicated as critical components of host resistance in pulmonary cryptococcosis and disseminated cryptococcosis (1, 18, 24-26). However, there is less understanding of the host resistance mechanisms that function directly in the brain, the organ most frequently involved with a fatal outcome of cryptococcosis. In light of the fact that the brain has a restrictive blood-brain barrier and unique effector cells (microglial cells and astrocytes) (10), it is not clear whether the same mechanisms (CD4⁺ T cells, IFN-, and so forth) that are important in anticryptococcal resistance in the lungs and other extracerebral tissues play a direct role in host defense in the brain or if they simply lower the C. neoformans burden in extracerebral tissues, resulting in less seeding of the organism into the brain.

In the present study, we wanted to determine whether or not anticryptococcal CMI mechanisms afford protection in the CNS. To ensure that the groups of mice being examined had the same number of organisms in the CNS at the start of the experiment, we used an intracerebral (i.c.) infection with viable C. neoformans cells. Because the same numbers of organisms were deposited directly into the CNS, the brain CFU in different comparative groups of mice (immune versus control) could be monitored to determine whether host responses affected the brain fungal burden. To induce a systemic anticryptococcal CMI response, mice were injected with a nonreplicating cryptococcal antigen (CneF) emulsified in incomplete Freund's adjuvant (IFA). Thus, using this murine model, we were able to induce an anticryptococcal CMI response with a nonreplicating antigen and monitor the effects of this systemically produced response on regional host resistance against C. neoformans in the CNS.

	MATERIALS AND METHODS

Top Abstract Introduction Materials and Methods Results Discussion References

Mice. Female inbred CBA/J mice purchased from Jackson Laboratory (Bar Harbor, Maine) were used at 7 to 10 weeks of age.

Maintenance of endotoxin-free conditions. The experimental conditions were maintained endotoxin free by using purchased endotoxin-free plasticware and heating all glassware for 3 h at 180°C. All reagents used in the experiments contained less than 8 pg of endotoxin/ml (minimal detectable level) when tested with the Limulus amebocyte lysate assay (Whittaker Bioproducts Inc., Walkersville, Md.).

Antigen preparation and analysis. The cryptococcal culture filtrate antigen (CneF) used for immunization and footpad and sponge injections was prepared from C. neoformans 184-A (38) as previously described (4). Briefly, a defined growth medium consisting of 2% dextrose, 0.4 mM thiamine, 1% trace elements (0.5 mg of CuSO₄ · 5H₂O, 200 mg of ZnSO₄ · 7H₂O, 3.2 mg of MnCl₂ · 4H₂O, 8 g of MgSO₄ · 7H₂O, 5.4 mg of Na₂MoO₄ · 2H₂O, and 5.7 mg of H₃BO₃ per liter of endotoxin-free water), 10 g of asparagine, 0.025 g of CaCl₂, and 0.4 g of K₂HPO₄ per liter of endotoxin-free water was prepared, and the pH was adjusted to 5.0. The medium was sterilized by autoclaving and inoculated with 10⁹ yeast cells/liter, and the culture was incubated for 5 days at 30°C. Following incubation, all cultures were examined microscopically for evidence of contamination, and Formalin (2% [vol/vol]) was added to kill the cryptococcal cells.

Induction and elicitation of the anticryptococcal delayed-type hypersensitivity (DTH) response. To induce an anticryptococcal CMI response, mice were injected subcutaneously at two sites at the base of the tail with 0.1 ml of a 1:1 emulsion of CneF in IFA. Control animals were injected in a similar manner with sterile endotoxin-free physiological saline emulsified 1:1 with IFA (saline-IFA).

3

i.v. and i.c. infections with C. neoformans. C. neoformans yeast cells taken from a 2-day culture on modified Sabouraud's agar were transferred to RPMI 1640 medium (Gibco, Gaithersburg, Md.) containing 10% heat-inactivated fetal bovine serum and incubated for 18 h at 37°C in 7% CO₂. The overnight culture was washed with sterile endotoxin-free physiological saline, counts were determined on a hemacytometer, and the culture was adjusted to the appropriate concentration for intravenous (i.v.) or i.c. injection. The numbers of viable C. neoformans cells injected were confirmed by culturing dilutions of the inoculum on modified Sabouraud's agar plates. i.v. infection was accomplished by injecting 0.2 ml of a prewarmed yeast cell suspension (2.5 × 10⁵ yeast cells/ml) through a 27-gauge needle into the tail vein.

Clearance of cryptococci from tissues. At designated times after infection, mice were sacrificed, and their brains, spleens, and lungs were removed and placed individually in sterile stomacher bags. The organs were homogenized in sterile saline with a Stomacher Lab 80 Lab Blender (Seward Medical, London, England). Serial 10-fold dilutions of each sample were plated in duplicate on modified Sabouraud's agar plates and incubated at room temperature for 2 to 3 days, and counts were determined.

Isolation of leukocytes from the CNS. Prior to staining for flow cytometry, leukocytes were separated from brain myelin debris by modifications of a previously published protocol (47). Mice were sacrificed and perfused with 40 ml of cold phosphate-buffered saline (PBS). Brains and spinal cords were pressed through 70-µm nylon mesh to form single-cell suspensions and were washed with cold Hanks balanced salt solution (HBSS). The cells were resuspended in 4 ml of 70% Percoll diluted in HBSS and placed in a 15-ml centrifuge tube. Four milliliters of 37% Percoll in HBSS was gently layered onto the cell suspension, followed by 4 ml of 30% Percoll. The Percoll gradients were centrifuged for 20 min at 500 × g and room temperature. The myelin debris was retained on the top of each gradient, and the leukocytes formed a band at the 37%-70% Percoll interface. The myelin debris was removed prior to collection of the leukocytes. The leukocytes were washed free of Percoll by centrifugation and counted on a hemacytometer.

Flow cytometric analysis. For analysis of surface markers, 10⁵ to 10⁶ cells isolated from brains were treated with Fc block (rat anti-mouse Fc- receptor; ATCC clone HB197) for 20 min on ice. The cells were pelleted, stained by resuspension in 100 µl (1 µg) of fluorochrome-labeled antibodies in staining buffer (PBS, 0.1% NaN₃, 0.1% bovine serum albumin), and incubated on ice for 30 min. The antibodies were phycoerythrin (PE)-anti-CD4, fluorescein isothiocyanate (FITC)-anti-CD8, FITC-anti-Ly-6G, and PE-anti-Mac-1 (CD11b) (all from Caltag, San Francisco, Calif.) and FITC-anti-CD45 (30F-11; leukocyte common antigen) (PharMingen, San Diego, Calif.). Appropriate fluorochrome-labeled isotype-matched control antibodies (PharMingen) were used to quantify the levels of nonspecific staining. After being washed in staining buffer, the cells were fixed with cold 1% paraformaldehyde in PBS containing 0.1% NaN₃ and analyzed on a FacStar⁺ flow cytometer. The samples were gated for cells of the subset of interest and then analyzed for staining with the specific fluorochrome-labeled antibody. In our experiments with the CBA/J strain of mice, Mac-1⁺ CD45^hi Ly-6G cells were macrophages, while Mac-1⁺ CD45^lo cells were considered microglial cells (43).

In vivo depletion of lymphocytes. Four groups of five mice were immunized with CneF-IFA 6 days prior to i.c. infection. CD4⁺ T lymphocytes were depleted from one group of mice by injecting 100 µg of purified anti-CD4 monoclonal antibody (clone GK1.5) intraperitoneally (i.p.). CD8⁺ T lymphocytes were depleted from another group with anti-CD8 monoclonal antibody (clone YTS 169.4). Mice were injected with monoclonal antibody 2 days prior to infection and again every other day thereafter. Additional groups of immunized mice received 100 µg of purified rat immunoglobulin G (Cappel, Aurora, Ohio) i.p. as an antibody control or no antibody treatment prior to i.c. infection. We found that administration of the isotype-matched control antibody did not affect the percentage and numbers of leukocytes in the animals, so to conserve animals and reagents, the isotype-matched control antibody-treated group was omitted from some experiments. The efficacy of depletion of a specific T-cell type was monitored by staining spleen cells from each group of mice with PE-conjugated rat anti-CD4, FITC-labeled rat anti-CD8, or appropriate fluorochrome-labeled isotype-matched control antibodies, followed by analysis on a FacStar⁺ flow cytometer. In every experiment, anti-CD4 and anti-CD8 treatments depleted CD4⁺ T lymphocytes and CD8⁺ T lymphocytes, respectively, without affecting the numbers of the other cell populations.

In vivo neutralization of IFN-. Three groups of mice (10 mice/group) were immunized with CneF-IFA. Six days after immunization, the mice were infected with 10³ C. neoformans i.c. To neutralize IFN- in vivo, one group of mice was injected i.p. with 0.5 ml of rabbit anti-murine IFN- serum on the same day as infection and every other day thereafter. Another group was injected i.p. with 0.5 ml of normal rabbit serum at the same times. The third group was not treated. On days 3 and 6 after infection, brains were removed and analyzed for CFU.

Statistical analysis. Means, standard errors of the means (SEM), and unpaired Student's t test and analysis of variance results were used to analyze the data. P values of 0.05 or less indicate statistical significance.

	RESULTS

Top Abstract Introduction Materials and Methods Results Discussion References

Immunization with CneF-IFA induces anticryptococcal clearance mechanisms that reduce the C. neoformans burden in the brain. Immunization with CneF-IFA induced an anticryptococcal CMI response, as measured by DTH reactivity to CneF. Mice immunized with CneF-IFA had mean ± SEM footpad swelling of (22.6 ± 2.8) × 10³ in, whereas the mean ± SEM increase in footpad thickness for control mice (saline-IFA treated) was (2.2 ± 0.37) × 10³ in. To assess the effects of immunization on disseminated infection, treated mice were infected i.v., and the brain fungal burden was monitored for 14 days (Table 1). CneF-IFA-immunized (immune) and saline-IFA-treated (control) mice had increasing brain fungal burdens through 7 days, with significantly fewer brain CFU in immune mice than in control mice. Brain CFU in immune mice declined thereafter, and the mice appeared healthy; however, control mouse brain CFU continued to increase, with some mortality of the mice.

Immunization with CneF-IFA induces protective mechanisms that function in the clearance of C. neoformans in the brain. The data in Table 1 suggest that the immunization protocol induced an anticryptococcal response capable of reducing the fungal burden in the brain. However, i.v. infection cannot address whether the lower brain CFU in immune mice was due to a regional immune response in the brain or the effect of reduced seeding of the brain with cryptococci in immune mice. To examine whether host resistance mechanisms participated in the clearance of C. neoformans in the CNS, equal numbers of cryptococci were introduced into the CNS of control and immune mice by i.c. injection. To ensure that the control and immune mice received the same numbers of cryptococci i.c., the numbers of organisms were cultured from the brains of five mice from each group at 1 h after infection. In every experiment, similar numbers were cultured from immune and control animals.

CD4⁺ T lymphocytes are present in C. neoformans-infected brains of immunoprotected mice. Once we had established that immune mice were able to limit the growth of C. neoformans in the CNS, we next examined what types of leukocytes were present in the CNS during infection. The results of a phenotypic analysis of leukocytes in the CNS of naive and infected mice are shown in Table 3. CneF-IFA-immunized mice injected i.c. with saline (mock infected) had about the same leukocyte numbers in the brain (data not shown) as naive mice (Table 3), indicating that immunization alone did not significantly affect the cellular makeup of the brain leukocyte population. Furthermore, mock-infected brains at 3 days after injection were not different from naive brains (data not shown), indicating that the i.c. injection itself did not induce an observable inflammatory response. In contrast, infected brains of CneF-IFA-immunized mice had increased numbers of neutrophils, CD4⁺ and CD8⁺ cells, and macrophages compared to infected brains of nonimmune control mice at both 3 and 7 days after infection. Leukocyte numbers continued to increase from day 3 to day 7 in both immune and nonimmune mice infected with C. neoformans. Microglial cell numbers at day 3 were larger in the brains of nonimmune mice, but by day 7, larger numbers of microglial cells were obtained from the brains of immune mice than from those of control mice. The predominant leukocyte types in the brains of infected immune mice at 3 and 7 days after infection were CD4⁺ T lymphocytes and macrophages, two cell types most closely associated with a CMI response.

Depletion of CD4⁺ T lymphocytes abrogates protection in the brain. CD4⁺ T lymphocytes are critical components of CMI responses and have been implicated in mediating cellular infiltration into C. neoformans-infected lungs (20, 22) and into anticryptococcal DTH reaction sites (4). Because we had observed increases in CD4⁺ and CD8⁺ T lymphocytes in infected brains of immune mice and both cell types have been shown to play some role in anticryptococcal CMI responses (20, 22, 34, 36), we examined whether or not depletion of CD4⁺ or CD8⁺ T cells affected the clearance of C. neoformans from the CNS of immune mice. Results from a representative experiment are shown in Fig. 1. Three days after infection, CD4-depleted immune mice had significantly larger numbers of cryptococcal CFU in their brains than immune mice given either no antibody or isotype-matched control antibody (P < 0.0005) (Fig. 1A). Depletion of CD8⁺ cells from immune mice had no effect on brain fungal burden. Seven days after infection, CD4-depleted immune mice had significantly larger numbers of cryptococci in their brains than immune mice treated with no antibody, isotype-matched control antibody, or anti-CD8 antibody (P < 0.0001) (Fig. 1B). There was no significant difference in the CFU numbers in the brains of immune mice treated with no antibody, isotype-matched control antibody, or anti-CD8 antibody on day 3 or 7 after infection.

View larger version (34K): [in this window] [in a new window]   FIG. 1.   CD4+ but not CD8+ T lymphocytes are required for growth inhibition of C. neoformans in the brains of immune mice. Brains of immune mice depleted of CD4+ T lymphocytes contained significantly more cryptococcal CFU than those of immune mice and CD8-depleted immune mice. Depletion of specific T-cell subsets by antibodies was confirmed by flow cytometric analysis of spleen cells from the treated mice. The data are representative of one of three experiments that yielded similar results. Ab, antibody.

Depletion of CD4⁺ T lymphocytes decreases leukocyte accumulation in the CNS of i.c. infected immune mice. The depletion data indicated that CD4⁺ T lymphocytes were critical for protective immunity against C. neoformans in the CNS; thus, we next asked whether CD4⁺ T lymphocytes were required for leukocyte accumulation in C. neoformans-infected brains of immune mice. The results from a CD4⁺ and CD8⁺ T-cell depletion experiment are shown in Fig. 2. Infected brains of immune mice depleted of CD4⁺ T lymphocytes contained significantly fewer leukocytes on day 6 after infection than infected brains of CD8-depleted immune mice or immune mice that had intact CD4⁺ and CD8⁺ T-lymphocyte populations (P < 0.02). The numbers of leukocytes isolated from C. neoformans-infected brains of CD8-depleted immune mice were no different from those in infected brains of immune mice not treated with antibody (Fig. 2).

View larger version (54K): [in this window] [in a new window]   FIG. 2.   CD4+ T lymphocytes are required for optimal leukocyte accumulation in C. neoformans-infected brains of immune mice. Brains and spinal cords of immune mice depleted of CD4+ T cells contained significantly fewer leukocytes 6 days after i.c. infection with C. neoformans than those of CD8+ T-cell-depleted immune mice and immune mice with both CD4+ and CD8+ T cells. Leukocytes from five or six mice from each group were obtained as described in Materials and Methods and counted. Depletion of specific T-cell subsets by antibodies was confirmed by flow cytometric analysis of spleen cells from treated mice. The experiment was repeated once, with similar results.

IFN- is required for optimal host resistance in the CNS of immune mice. Because CD4⁺ T lymphocytes are major sources of IFN- and IFN- has been shown to be important in host defense against C. neoformans (1, 18, 24-26), we next asked whether depletion of IFN- affected clearance in the CNS of immune mice. Brains of immune mice given neutralizing antibody to IFN- (Fig. 3) had significantly more cryptococcal CFU at 3 days after i.c. infection than brains of immune mice given either no antibody (P, <0.04) or control serum (P, <0.05) (Fig. 3A). At day 6 after i.c. infection, the difference in brain CFU between immune mice given anti-IFN- serum and immune mice given normal serum (P, <0.009) or no serum (P, <0.007) was more pronounced.

View larger version (29K): [in this window] [in a new window]   FIG. 3.   IFN- is required for optimal host resistance in the CNS of immune mice. Cryptococcal CFU in brains of i.c. infected immune mice given neutralizing antibodies to IFN- were significantly higher than those in i.c. infected immune mice given no antibody or control antibody. Five mice were used per group.

	DISCUSSION

Top Abstract Introduction Materials and Methods Results Discussion References

CMI has been shown to be important in host protection in pulmonary cryptococcosis and systemic cryptococcosis (6, 14, 15, 17, 20, 22, 23, 31, 32, 35, 41, 46). However, it has been unclear whether a protective anticryptococcal response can function directly in the clearance of C. neoformans once the organism is in the brain or whether it only reduces the organism burden in tissues outside the CNS, thereby reducing the number of cryptococci that reach the brain. Although infection with C. neoformans is generally thought to be acquired by inhalation, the majority of cryptococcosis patients are not diagnosed until signs of CNS involvement are present. The current antifungal therapies are not completely effective in eradicating the organism; thus, a better understanding of the host response in the CNS would be beneficial in developing new immune-based therapies.

The present study describes a cryptococcal i.c. infection model involving immunocompetent mice immunized with a cryptococcal antigen, CneF. The advantage of this model over other infection models is that i.c. infection introduces the organisms directly into the CNS so that comparative groups begin with the same numbers of organisms in the CNS. In addition, immunization with CneF induces a systemic protective CMI response without introducing replicating cryptococci. Thus, clearance of the organisms from the CNS can be studied under conditions where activated T lymphocytes specific for cryptococcal antigens are present systemically (39) and all organisms present in tissues initiated from a regional CNS infection.

The data presented here demonstrate that infection by i.c. injection of organisms resulted in a regional CNS infection with limited dissemination to extracerebral tissues. Immune mice contained fewer brain CFU than control mice, indicating that a protective anticryptococcal CMI response induced systemically can function in inhibiting the growth of C. neoformans in the CNS. Protective immunity correlated with leukocyte recruitment into the CNS. Others have observed cellular infiltration in the brains of mice (1, 2, 21), rats (13), and humans (28, 29) infected with C. neoformans; thus, the host can mount an inflammatory response against the organism in the brain. We extended these observations by demonstrating that cellular infiltration into infected brains of immune mice included the accumulation of T lymphocytes, macrophages, and neutrophils, presumably by migration from the peripheral blood into the CNS. The pattern of cellular infiltration into infected brains of immune mice was reminiscent of anticryptococcal CMI responses in other tissues (4, 5). Furthermore, CD4⁺ T lymphocytes were required for optimal recruitment or intracerebral expansion of leukocytes in the CNS.

Hill and Aguirre (16) reported that the presence of CD4⁺ T lymphocytes in mice correlates with reduced fungal burden in the brains of mice infected either intratracheally or i.v. However, the issue of whether clearance of the cryptococci occurred in the CNS or extracerebrally, leading to reduced seeding of the brain from the bloodstream, was not addressed. In our study, the observation that significantly fewer cryptococci were present in the brains of immune mice within 1 day after i.v. infection than in those of control mice (Fig. 1) suggests that at least some clearance occurs extracerebrally. Our data obtained with the i.c. infection model unequivocally demonstrate that CD4⁺ cells are required for inhibiting the growth of C. neoformans in the CNS of mice immunized with a cryptococcal antigen.

We also observed increases in the numbers of CD8⁺ T lymphocytes in infected brains of immune mice, although the numbers were considerably lower than those of CD4⁺ T lymphocytes. Others have reported CD8⁺ T lymphocytes present along with CD4⁺ T lymphocytes in rat brains infected with C. neoformans (13). CD8⁺ T lymphocytes have been shown to play a role in the development of an anticryptococcal DTH response following immunization with heat-killed C. neoformans or intratracheal infection with viable C. neoformans (34, 36). CD8⁺ T lymphocytes have also been shown to be important in host resistance against C. neoformans following pulmonary infection (17, 20, 22, 34). The role of CD8⁺ T lymphocytes in host protection against C. neoformans in human cryptococcal meningoencephalitis is unknown; however, our results indicate that CD8⁺ T lymphocytes are not required for optimal leukocyte recruitment and early growth inhibition of C. neoformans in the CNS of mice immunized with CneF. Immunization with CneF in complete Freund adjuvant does not induce CD8⁺ T lymphocytes, and CD8⁺ T lymphocytes are not needed for a DTH response or host resistance in mice immunized with CneF in complete Freund adjuvant (40). Presumably, CD8⁺ T lymphocytes are not induced by CneF-IFA as well. Thus, at this time, it is unclear whether the lack of requirement for CD8⁺ T lymphocytes in the CNS resistance that we observed is due to the type of immune response generated by immunization with a cryptococcal antigen or is a general phenomenon associated with host resistance against C. neoformans in the CNS.

The numbers of neutrophils and microglial cells were also increased in infected brains of immune mice. Neutrophils are commonly found in CMI reactions in mice (8), and we have observed abundant neutrophils at sites of anticryptococcal CMI responses (4, 5). Others have reported neutrophils present in a rat model of cryptococcal meningitis (13) and in brain sections from non-AIDS patients with cryptococcal meningoencephalitis (28, 29). In AIDS-associated cryptococcal meningoencephalitis, the primary leukocytes observed in the brain were macrophages, with few neutrophils (28, 29). Our data on immune mice depleted of CD4⁺ T lymphocytes having reduced numbers of neutrophils during infection are in agreement with the observations of leukocyte types in AIDS patients reported by Lee and colleagues (28, 29). Thus, T lymphocytes may be required for recruitment of neutrophils into the CNS in cryptococcosis. The role of neutrophils in CNS protection against C. neoformans, as well as the detrimental effects of the liberation of neutrophil products on host tissue during infection, has yet to be determined.

Microglial cells are resident macrophage-like cells of the CNS (12) that have the ability to kill cryptococci in vitro (3, 30). Because microglial cells are resident cells of the CNS, one might not expect to see changes in their numbers in the CNS as a result of infection; however, we observed a dramatic increase after i.c. introduction of C. neoformans. The increase in microglial cell numbers in infected brains of immune mice might have been due to either proliferation or changes in the cellular environment during the immune response that allowed them to be isolated in larger numbers from the CNS. Recently, Sedgwick and colleagues (44) reported a threefold increase in the number of isolated microglial cells over a 3-day period in a rat model of CNS graft-versus-host disease. They proposed that this increase was due to T-cell-induced microglial cell proliferation in the CNS (44). It is unclear at this time what mechanism is responsible for increased microglial cell numbers in our model.

Cellular infiltration was also evident in infected brains of control mice, although the magnitude of the inflammatory response was considerably lower and delayed in comparison to that in infected immune mouse brains. The cellular infiltration observed in infected control mice likely was due in part to the generation of an anticryptococcal CMI response and the subsequent recruitment of leukocytes to the site of infection by components of this response. In fact, control mice exhibited significant DTH reactivity by 7 days after i.c. infection (data not shown).

IFN- has been shown to be important in protection against C. neoformans in animal models (1, 18, 24-26). We observed that IFN- was essential for optimal growth inhibition when C. neoformans was introduced directly into the CNS of immune mice. Because IFN- activates macrophages to better kill cryptococci (11, 37), protection mediated via IFN- is presumably due to the activation of effector cells already present at the site of infection or recruited to the site. Thus, the cryptococcal growth inhibition that we observed in the brains of immune mice likely is due in part to the production of IFN-, which activates macrophages recruited to the CNS or endogenous effector cells, such as microglial cells or astrocytes, to kill the cryptococci.

In summary, our data demonstrate that CD4⁺ T lymphocytes induced by immunization with a cryptococcal antigen are present in the CNS of C. neoformans-infected mice. These CD4⁺ T lymphocytes are required for optimal accumulation of macrophages and neutrophils in the CNS, and the inflammatory response generated results in a reduction in the cryptococcal burden in the CNS, potentially by an IFN--dependent mechanism.